首页 | 本学科首页   官方微博 | 高级检索  
检索        

通心络胶囊对急性冠脉综合征高敏C反应蛋白及血小板活化功能的影响
引用本文:卢孔杰,韦凡平,张宗新.通心络胶囊对急性冠脉综合征高敏C反应蛋白及血小板活化功能的影响[J].实用中医药杂志,2007,23(7):416-417.
作者姓名:卢孔杰  韦凡平  张宗新
作者单位:1. 湖州市中心医院浙江,湖州313000
2. 湖州市师范学院附属医院,浙江,湖州313000
摘    要:目的:探讨通心络胶囊对急性冠脉综合征患者高敏C反应蛋白(hs-CRP)、血小板胞浆内α-颗粒上的膜糖蛋白(CD62p)及溶酶体膜糖蛋白(CD63)的影响。方法:73例随机分为治疗组37例和对照组36例,两组均予常规治疗。治疗组于入院后24h内加用通心络胶囊治疗。结果:两组hs-CRP、CD62p、CD63水平,变化有极显著性差异(P<0.01),治疗4周后即可显现,8周后更为明显。结论:早期应用通心络胶囊可进一步降低急性冠脉综合征患者hs-CRP、CD62p、CD63水平。

关 键 词:急性冠脉综合征  通心络胶囊  高敏C反应蛋白  血小板活化
文章编号:1004-2814(2007)07-416-02
修稿时间:2007-04-20

Effect of Tongxinluo Capsule on High Sensitve C Reactive Protein and Mobilizing Function of Thrombocyte
Lu Kongjie,Wei Fanping,Zhang Zongxin.Effect of Tongxinluo Capsule on High Sensitve C Reactive Protein and Mobilizing Function of Thrombocyte[J].Journal of Practical Traditional Chinese Medicine,2007,23(7):416-417.
Authors:Lu Kongjie  Wei Fanping  Zhang Zongxin
Abstract:Objective : To approach the effect of Tongxinluo Capsule on hs-CRP, CD62p and CD63 of acute coronary syndrome patients. Method:73 cases were divided into two groups randomly,37 cases as the study group and 36 cases as the control group. Both groups were treated with conventioal therapy. The study group was treated with Tongxinluo Capsule additionally when 24 hours after hospital admission. Result: There is very significant difference in the level of hs-CRP, CD62p and CD63 between the two groups (P<0.01) after 4 weeks and the difference is more obvious after 8 weeks. Conclusion: Togxinluo Capsule used in early stage of acute coronary syndrome could lower the level of hs-CRP, CD62p and CD63.
Keywords:acute coronary syndrome  Tongxinluo Capsule  hs-CRP  thrombocyte activation  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号